Biotech Pioneer Amgen Joins Hunt for Coronavirus Drug

Must Read

Read Black Clover Manga 244, Spoilers Date, Chapter 244

Read Black Clover Manga 244 spoilers date will reveal to us progressively about the battle and who precisely Asta's...

Read One Punch Man Webcomic Online & Cartoon HD App

One Punch Man Webcomic Online is a continuous web-comic of Japan that was made by Pseudonym One. He began...

Arrow Video has announced its 4K Blu-ray release – Vin Diesel’s ‘Pitch Black’

Arrow Video breaks into the 4K Ultra HD arena with the up and coming release of Pitch Black, the...

Stardom Wrestling Update: Hana Kimura has passed away at the age of 22

The Stardom Wrestling Twitter account is announcing that Hana Kimura has passed away at 22 years old. Kimura was managing...

Google Alternatives: “Hey Google alternative” or “Ok Google alternative”

Here is the quick lookup of the OK/Hey Google alternatives ( Ok google alternative/Hey google alternative): The Google Home...
- Advertisement -
- Advertisement -




A scientist working at the Amgen campus in California.

Photo: Roger Kisby for the Wall Street Journal

Big biotech company Amgen Inc. AMGN 0.10% is joining the race to discover new drugs that can treat the novel coronavirus, the latest drugmaker redirecting resources toward the pandemic.

Amgen, which is partnering with Adaptive Biotechnologies Corp. ADPT 1.24% in the effort, is an unlikely hunter of antiviral treatments. The company, a pioneer of biotechnology, is best known for its drugs for cancer, with other products targeting high cholesterol, kidney disease and migraines.

Although it lacks infectious-disease expertise, Amgen, of Thousand Oaks, Calif., believes it might have something to contribute to fighting the pandemic because of its expertise in antibody drugs. In the treatment of viruses, the drugs aim to hunt down the pathogens, attach to them and then stop them from wreaking havoc.

  1. confirmed cases in the U.S.
  2. total deaths in the U.S.
Source: Johns Hopkins Center for Systems Science and Engineering

The antibody strategy has been used to develop a treatment for Ebola, and is being pursued in Covid-19 by several companies and academic labs including Vir Biotechnology Inc. and AbCellera Biologics Inc.

As the virus has spread, more companies across the industry are diverting researchers toward coronavirus drug and vaccine discovery.

Now, more than 115 companies are trying to develop drugs or vaccines for Covid-19, the disease caused by the coronavirus, according to Informa Pharma Intelligence, a data provider. Among the biggest entrants are Johnson & Johnson, Gilead Sciences Inc. and Regeneron Pharmaceuticals Inc.

“We don’t view this as a competition, but a moment when it’s all hands on deck to address the crisis,” David Reese, Amgen’s executive vice president of research and development, said in an interview.

Most of the companies pursuing anti-coronavirus agents are still in the very early stages of research, with about 93% of the 121 drugs in development yet to enter clinical trials, according to the Informa data.

Amgen and Adaptive’s drug, if it emerges, would be used to treat infected patients and help clear the virus from their bodies, Dr. Reese said. It could also potentially prove effective at providing temporary prophylactic protection for healthy people, such as front-line health-care workers at high risk of exposure, he said.

Amgen and Adaptive said they haven’t yet finalized financial details of the agreement, but are planning to start their research immediately given the urgency of the pandemic. Adaptive, based in Seattle, will be responsible for the first stage of discovery, and Amgen will handle clinical trials and manufacturing if the drug is ultimately approved.

In the first stage, Adaptive will identify the most promising antibodies against the coronavirus by analyzing the genetic sequences of immune cells from Covid-19 survivors. Amgen will choose the most promising antibody, or possibly a combination of two or more, to advance into clinical trials.

It may take five to six months for Adaptive to complete its portion of the antibody work, Chief Executive Chad Robins said in an interview. Adaptive’s gene-analysis technology is aimed at deciphering the immune system, and is used by pharmaceutical companies in drug development, clinical trials and other areas.

An Amgen subsidiary, deCODE Genetics, is conducting a continuing study of the genetic profiles of Covid-19 patients in Iceland. The analysis will provide Amgen with information about the genetic characteristics of patients who have survived the virus, the companies said.

In addition, the deCODE study is tracking the disease’s transmission in Iceland, where deCODE is based, as well as helping to predict which patients are most likely to develop serious illness after infection, Dr. Reese said.

Amgen and deCODE plan to publish all data from the study as quickly as possible, including genetic data providing insight into the disease, an Amgen spokeswoman said. The companies expect early findings from the study to be published soon in a medical journal.

More on Coronavirus

Copyright ©2019 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Join Wall Street Journal For Just $1
Credit: WSJ.com



- Advertisement -

Latest News

- Advertisement -

Top 10 Best Anime Sites to Watch Anime Online Free

Top 10 Best Anime Sites to Watch Anime Online Free - Best anime sites 2016 too 2020: Japan anime is currently gaining an increasing...

Best Sites To Check Internet Speed In 2020

A super-quick internet connection is everybody's inward wish these days. Indeed, internet access is so significant in the present time different nations have made...
- Advertisement -
- Advertisement -

Read One Punch Man Webcomic Online & Cartoon HD App

One Punch Man Webcomic Online is a continuous web-comic of Japan that was made by Pseudonym One. He began its production in mid-2009 and...

One punch Man Season 2 Crunchyroll – Viz Media Partnership

One punch Man Season 2 Crunchyroll Ridiculously recap Saitama may be also a man who's a fanatic for pleasure and also your most powerful man on...

One Punch Man Webcomic – Manga Review

One Punch Man Webcomic: A week ago I looked into and thought about One Punch Man's 3 distinct media – the anime, webcomic, and...
- Advertisement -

More Articles Like This

- Advertisement -